Lux Ventures VIII-B

Lux Ventures VIII-BLux Ventures VIII-B
Lux Ventures VIII-B

Lux Ventures VIII-B

Investing in audacious founders turning breakthrough science and technology into reality across deep tech sectors.

Venture Capital26 portfolio$3.3B AUMNew York, NY

About

Lux Capital is a venture capital firm that backs scientists, technologists, and inventors who are challenging the status quo and the laws of nature to bring futuristic ideas to life. The firm focuses on contrarian, long-term investments in emerging science and deep technology companies, often at pre-product and pre-company stages. They aim to support companies that leverage advanced science and technology to disrupt industries and solve complex problems.
Frequently asked

What type of investor is Lux Ventures VIII-B?

Lux Capital is a venture capital firm that backs scientists, technologists, and inventors who are challenging the status quo and the laws of nature to bring futuristic ideas to life. The firm focuses on contrarian, long-term investments in emerging science and deep technology companies, often at pre-product and pre-company stages. They aim to support companies that leverage advanced science and te…

What kind of firm is Lux Ventures VIII-B?

Lux Ventures VIII-B is a Venture Capital.

What is Lux Ventures VIII-B's assets under management?

Lux Ventures VIII-B manages approximately $3.3B in assets.

Where is Lux Ventures VIII-B based?

Lux Ventures VIII-B is based in New York, NY.

What sectors does Lux Ventures VIII-B focus on?

Lux Ventures VIII-B focuses on AI, Biotechnology, Aerospace, Defense.

AUM
$3.3B
PORTFOLIO
26
Scores
Measured, not editorial
Domain Rating
67/100

Strength of the site’s backlink profile, on the industry-standard 0-100 scale. Licensed third-party data, not our opinion.

Check any domain free

Star ratings come from visitors, one per person per profile, and are shown exactly as given: we do not weight, curate or filter them. Reviews are published in full alongside the rating that accompanied them.

Comments

No comments yet. Be the first to share your take.